Ondatron

Molecule: Ondansetron

Formulation: Ondansetron 2mg/ml, 2ml Inj.

Packaging Unit: 1 Amp Injection

Dosage: Injection: Adults and Pediatric patients (6 months to 18 years): Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes. The first dose should be administered 30 minutes before the start of chemotherapy. Subsequent doses are administered 4 and 8 hours after the first dose.

View PDF

Molecule: Ondansetron

Formulation: Ondansetron 2mg/5ml, 30ml, Syrup

Packaging Unit: 30ml Syrup

Dosage: Oral tab/syrup: For highly emetogenic chemotherapy 24 mg given as three 8-mg tablets administered 30 minutes before the start of single-day highly emetogenic chemotherapy, including cisplatin > 50 mg/m2. Pediatric Use: There is no experience with the use of a 24mg dosage in pediatric patients. Geriatric Use: The dosage recommendation is the same as for the general population. For moderately emetogenic chemotherapy.

View PDF

Molecule: Ondansetron

Formulation: Ondansetron 4mg Mouth Dissolving Tablet

Packaging Unit: 1x4T Mouth Dissolving Tablets

Dosage: Tablets - 8 mg twice a day, first dose 30 minutes before chemotherapy. To be continued for 1 to 2 days after completion of chemotherapy. Pediatric Use: For pediatric patients 12 years of age and older, the dosage is the same as for adults. For pediatric patients 4 through 11 years of age, the dosage is 4 mg Ondatron solution given 3 times a day. The first dose should be administered 30 minutes before the start of emetogenic chemotherapy, with subsequent doses 4 and 8 hours after the first dose. To be continued for 1 to 2 days after completion of chemotherapy. Geriatric Use: The dosage is the same as for the general population.

View PDF